Valuation Collegium Pharmaceutical, Inc.

Stocks

Market Closed - Nasdaq 00:00:00 14/11/2026 +03			5-day change	1st Jan Change
25.32 ^USD	+1.48%		+4.58%	-45.31%

11-13	Barclays Adjusts Collegium Pharmaceutical Price Target to $41 From $48, Maintains Overweight Rating	MT
11-05	Collegium Pharmaceutical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	650	778.9	1,004	924	1,464	786.8	-	-
Change	-	19.82%	28.87%	-7.95%	58.4%	-46.24%	-	-
Enterprise Value (EV)	650	778.9	1,004	924	1,464	786.8	786.8	786.8
Change	-	19.82%	28.87%	-7.95%	58.4%	-46.24%	0%	0%
P/E	10x	-31.4x	23.9x	15.4x	26.8x	24.3x	11.6x	6.57x
PBR	-	-	-	-	-	-	-	-
PEG	-	0x	-0x	0.3x	-3.83x	-0.6x	0x	0.1x
Capitalization / Revenue	2.35x	1.68x	1.77x	1.46x	1.88x	0.95x	0.93x	0.91x
EV / Revenue	0x	0x	0x	0x	0x	0.95x	0.93x	0.91x
EV / EBITDA	0x	0x	0x	0x	0x	1.83x	1.89x	2.02x
EV / EBIT	0x	0x	0x	0x	0x	1.77x	1.87x	1.98x
EV / FCF	-	-	0x	0x	0x	2.8x	2.19x	1.99x
FCF Yield	-	-	27.3%	22%	22.4%	35.8%	45.6%	50.2%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	1.86	-0.74	1.29	1.86	1.73	1.04	2.18	3.855
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	276.9	463.9	566.8	631.4	780.6	832	847.7	861.5
EBITDA ¹	118.3	266	367	401.2	460.5	430.9	415.7	389.9
EBIT ¹	17.63	33.32	167	169.9	179.6	444.7	419.9	397.6
Net income ¹	71.52	-25	48.16	69.19	62.87	41.92	80.65	139.5
Net Debt	-	-	-	-	-	-	-	-
Reference price ²	18.68	23.20	30.78	28.65	46.30	25.32	25.32	25.32
Nbr of stocks (in thousands)	34,797	33,572	32,611	32,250	31,611	31,075	-	-
Announcement Date	2/24/22 A	2/23/23 A	2/22/24 A	2/27/25 A	2/26/26 A	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
COLLEGIUM PHARMACEUTICAL, INC.	24.35x	-	-	-	787M
ELI LILLY AND COMPANY	42.25x	14.3x	30.31x	0.47%	1,286B
JOHNSON & JOHNSON	41.82x	7.01x	19.73x	1.87%	688B
ABBVIE INC.	37.62x	8.63x	17.81x	2.34%	521B
ROCHE HOLDING AG	21.75x	5.27x	13.2x	2.48%	386B
MERCK & CO., INC.	104.88x	5.98x	25.49x	2.3%	364B
NOVARTIS AG	24x	5.82x	14.17x	2.73%	302B
ASTRAZENECA PLC	24.25x	4.85x	13.63x	1.8%	287B
AMGEN INC.	24.04x	7.38x	13.56x	2.17%	252B
GILEAD SCIENCES, INC.	-39.49x	7.32x	46.07x	1.96%	208B
Average	30.55x	7.40x	21.55x	2.01%	430B
Weighted average by Cap.	37.57x	8.95x	22.68x	1.68%